ClinicalTrials.Veeva

Menu

Absolute Quantification in Bone Scintigraphy (QUANTOSS-3D)

C

Central Hospital, Nancy, France

Status

Completed

Conditions

Scintigraphy Quantification

Treatments

Device: SPECT CT

Study type

Observational

Funder types

Other

Identifiers

NCT04671238
2020PI241

Details and patient eligibility

About

While absolute quantification in 18F-FDG PET (Positon Emission Tomography) is widely used in clinical routine, absolute quantification in SPECT (Single Photon Emission Computed Tomography) is under development and its clinical interest remains to be demonstrated. Recent studies carried out on bone scan recordings show the potential interest of quantification indexes such as SUV (Standard Uptake Value).

Full description

In oncology, bone scan studies have reported significantly higher SUV values for secondary bone lesions compared with benign osteoarticular lesions , and some have even defined an SUVmax threshold value that points to prostatic bone metastases.

Enrollment

21 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with recent vertebral fractures:

    1. who have had at least two SPECT/CT scan scans of the spine as part of a pre-vertebroplasty check-up,
    2. for which fracture dates were known.

Exclusion criteria

  1. Minor person
  2. Person opposing the use of their data (Posters in waiting rooms explaining that the patient must object if they do not wish their data to be used)

Trial design

21 participants in 1 patient group

Patient for SPECT/CT scan
Description:
Patients referred for SPECT/CT scan of the spine as part of a vertebroplasty workup and selected retrospectively.
Treatment:
Device: SPECT CT

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems